BSE surges as October F&O premium turnover almost doubles August low

Market pulse

From the investor's mind

The clinical and adult nutrition sector is poised to become a massive category driven by the rising global demand for GLP-1 weight-loss medications. As Ishmohit Arora from SOIC points out, patients taking GLP-1 drugs frequently skip meals due to the appetite-suppressing effects of the medication. This behavioral shift creates a specific nutritional gap, directly boosting the demand for high-protein dietary supplements as well as targeted vitamins and minerals to maintain muscle mass and general health. For investors, this structural shift highlights how the rapid adoption of weight-loss drugs is creating a major, fast-growing secondary market in specialized consumer healthcare and nutrition.

Word in the street

BSE Limited

BSE Limited is dominating investor conversations after its stock climbed 42.78 percent over the past year, taking its market capitalization to about 163,979 crore. Market participants are celebrating October as the best month so far for the BSE F&O average daily premium turnover, which reached 36,759 crore. This performance represents a strong comeback that almost doubles the low recorded in August, aided by higher volatility and five Thursdays in October. Investors are now looking forward to December when a rollback of CAS is expected to bring back some of the trading volume that was previously lost.

Yesterday's big moves

“Invest like a bull, sit like a bear, and watch like an eagle.”

Vijay Kedia